Zhejiang Int'L Group000411.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 19, 2026, Zhejiang Int'L Group (000411.SZ) trades at a P/E of 12.30x, P/B of 1.00x, P/S of 0.16x, and a dividend yield of 3.62%.
Longitudinal percentile comparison: P/E sits at the 22nd percentile over the trailing 10Y window (vs. 68th percentile over 3Y); P/B sits at the 2nd percentile over the trailing 10Y window (vs. 6th percentile over 3Y); P/S sits at the 50th percentile over the trailing 10Y window (vs. 23rd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 4th percentile within its industry and the 8th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.62%, ranking at the 98th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 19.5 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Zhejiang Int'L Group operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 000411 · SZSE: 000411 · 000411
Want the full picture on whether Zhejiang Int'L Group (000411.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 12.30 | ||||||
| P/B (MRQ) | 1.00 | ||||||
| P/S (TTM) | 0.16 | ||||||
| Dividend Yield | 3.62% | ||||||
| Buyback + Div Yield | 3.62% |